SK5999A3 - 1-isothiazolidinone derivatives of azetidine-2-one, process for the preparation thereof and the use thereof - Google Patents

1-isothiazolidinone derivatives of azetidine-2-one, process for the preparation thereof and the use thereof Download PDF

Info

Publication number: SK5999A3
Authority: SK; Slovakia
Prior art keywords: hydrogen; benzyl; compound; chlorine; bromo
Prior art date: 1998-01-20

Application number

SK59-99A

Other languages

English (en)

Slovak (sk)

Inventor

Jure J Herak

Original Assignee

Pliva Pharm & Chem Works

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-20

Filing date

1999-01-15

Publication date

2000-04-10

1999-01-15 Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works

2000-04-10 Publication of SK5999A3 publication Critical patent/SK5999A3/sk

Links

238000000034 method Methods 0.000 title claims description 10
238000002360 preparation method Methods 0.000 title abstract description 9
WWCWNTFURYWCHX-UHFFFAOYSA-N 1,2-thiazolidine 1-oxide Chemical class O=S1CCCN1 WWCWNTFURYWCHX-UHFFFAOYSA-N 0.000 title 1
229910052739 hydrogen Inorganic materials 0.000 claims abstract description 51
239000001257 hydrogen Substances 0.000 claims abstract description 46
150000001875 compounds Chemical class 0.000 claims abstract description 22
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 15
125000003118 aryl group Chemical group 0.000 claims abstract description 7
MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical group O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 claims abstract description 7
125000000217 alkyl group Chemical group 0.000 claims abstract description 6
125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 6
125000005843 halogen group Chemical group 0.000 claims abstract description 6
125000005842 heteroatom Chemical group 0.000 claims abstract description 6
125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 6
125000000842 isoxazolyl group Chemical group 0.000 claims abstract description 6
150000003952 β-lactams Chemical group 0.000 claims abstract description 5
125000005543 phthalimide group Chemical group 0.000 claims abstract description 4
125000003226 pyrazolyl group Chemical group 0.000 claims abstract description 3
150000002431 hydrogen Chemical class 0.000 claims description 28
-1 2-phenyl-pyrazol-3-yl Chemical group 0.000 claims description 19
229910052736 halogen Inorganic materials 0.000 claims description 14
150000002367 halogens Chemical class 0.000 claims description 14
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 10
239000011541 reaction mixture Substances 0.000 claims description 10
238000006243 chemical reaction Methods 0.000 claims description 6
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 5
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 5
229910052757 nitrogen Inorganic materials 0.000 claims description 5
229910052760 oxygen Inorganic materials 0.000 claims description 5
239000001301 oxygen Substances 0.000 claims description 5
239000011593 sulfur Substances 0.000 claims description 5
229910052717 sulfur Inorganic materials 0.000 claims description 5
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 4
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 3
239000003795 chemical substances by application Substances 0.000 claims description 3
IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims description 3
229910000041 hydrogen chloride Inorganic materials 0.000 claims description 3
HFRXJVQOXRXOPP-UHFFFAOYSA-N thionyl bromide Chemical compound BrS(Br)=O HFRXJVQOXRXOPP-UHFFFAOYSA-N 0.000 claims description 3
229910000042 hydrogen bromide Inorganic materials 0.000 claims description 2
238000004519 manufacturing process Methods 0.000 claims description 2
YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 claims description 2
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 9
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 9
239000000460 chlorine Substances 0.000 claims 9
229910052801 chlorine Inorganic materials 0.000 claims 9
125000001246 bromo group Chemical group Br* 0.000 claims 7
125000001309 chloro group Chemical group Cl* 0.000 claims 3
UEFCKYIRXORTFI-UHFFFAOYSA-N 1,2-thiazolidin-3-one Chemical group O=C1CCSN1 UEFCKYIRXORTFI-UHFFFAOYSA-N 0.000 claims 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
230000000844 anti-bacterial effect Effects 0.000 claims 1
239000000010 aprotic solvent Substances 0.000 claims 1
125000002393 azetidinyl group Chemical group 0.000 claims 1
230000015572 biosynthetic process Effects 0.000 claims 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
229910052794 bromium Inorganic materials 0.000 claims 1
230000001143 conditioned effect Effects 0.000 claims 1
230000026030 halogenation Effects 0.000 claims 1
238000005658 halogenation reaction Methods 0.000 claims 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
125000001984 thiazolidinyl group Chemical group 0.000 claims 1
239000000203 mixture Substances 0.000 abstract description 8
239000000543 intermediate Substances 0.000 abstract description 4
125000000623 heterocyclic group Chemical group 0.000 abstract description 3
239000013543 active substance Substances 0.000 abstract 1
238000011203 antimicrobial therapy Methods 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 30
239000006260 foam Substances 0.000 description 16
OAMZXMDZZWGPMH-UHFFFAOYSA-N ethyl acetate;toluene Chemical compound CCOC(C)=O.CC1=CC=CC=C1 OAMZXMDZZWGPMH-UHFFFAOYSA-N 0.000 description 14
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
238000004587 chromatography analysis Methods 0.000 description 11
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
239000000741 silica gel Substances 0.000 description 10
229910002027 silica gel Inorganic materials 0.000 description 10
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
238000011282 treatment Methods 0.000 description 9
101100208721 Mus musculus Usp5 gene Proteins 0.000 description 7
230000008707 rearrangement Effects 0.000 description 6
FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
238000002425 crystallisation Methods 0.000 description 5
230000008025 crystallization Effects 0.000 description 5
239000000047 product Substances 0.000 description 5
239000000243 solution Substances 0.000 description 5
ZUWRNQXDZVFRGF-NUHJPDEHSA-N (4s)-2-benzyl-4-(3,3-dibromo-2-chloro-4-oxoazetidin-1-yl)-5,5-dimethyl-1,1-dioxo-1,2-thiazolidin-3-one Chemical class N1([C@@H]2C(S(N(CC=3C=CC=CC=3)C2=O)(=O)=O)(C)C)C(Cl)C(Br)(Br)C1=O ZUWRNQXDZVFRGF-NUHJPDEHSA-N 0.000 description 4
NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 4
239000012043 crude product Substances 0.000 description 4
239000007858 starting material Substances 0.000 description 4
CLNDZLBRPTYBPL-JQWIXIFHSA-N (4s)-2-benzyl-4-[(2r)-3,3-dibromo-2-chloro-4-oxoazetidin-1-yl]-5,5-dimethyl-1,2-thiazolidin-3-one Chemical compound CC([C@H](C1=O)N2C(C(Br)(Br)[C@H]2Cl)=O)(C)SN1CC1=CC=CC=C1 CLNDZLBRPTYBPL-JQWIXIFHSA-N 0.000 description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Natural products N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
239000012153 distilled water Substances 0.000 description 3
239000012044 organic layer Substances 0.000 description 3
239000011734 sodium Substances 0.000 description 3
239000000126 substance Substances 0.000 description 3
BYDOGQKHDYKYAS-GTXICJSNSA-N (2s,4s,5r,6s)-2-benzyl-6-bromo-3,3-dimethyl-4,7-dioxo-4$l^{4}-thia-1-azabicyclo[3.2.0]heptane-2-carboxamide Chemical compound C([C@]1(N2C(=O)[C@H](Br)[C@H]2[S@@](=O)C1(C)C)C(N)=O)C1=CC=CC=C1 BYDOGQKHDYKYAS-GTXICJSNSA-N 0.000 description 2
KGHZYCDDAMUAGN-WOPDTQHZSA-N (4s)-2-benzyl-4-[(2r,3s)-3-bromo-2-chloro-4-oxoazetidin-1-yl]-5,5-dimethyl-1,2-thiazolidin-3-one Chemical compound CC([C@H](C1=O)N2C([C@H](Br)[C@H]2Cl)=O)(C)SN1CC1=CC=CC=C1 KGHZYCDDAMUAGN-WOPDTQHZSA-N 0.000 description 2
ZUWRNQXDZVFRGF-CMPLNLGQSA-N (4s)-2-benzyl-4-[(2s)-3,3-dibromo-2-chloro-4-oxoazetidin-1-yl]-5,5-dimethyl-1,1-dioxo-1,2-thiazolidin-3-one Chemical compound N1([C@@H]2C(S(N(CC=3C=CC=CC=3)C2=O)(=O)=O)(C)C)[C@@H](Cl)C(Br)(Br)C1=O ZUWRNQXDZVFRGF-CMPLNLGQSA-N 0.000 description 2
CLNDZLBRPTYBPL-CMPLNLGQSA-N (4s)-2-benzyl-4-[(2s)-3,3-dibromo-2-chloro-4-oxoazetidin-1-yl]-5,5-dimethyl-1,2-thiazolidin-3-one Chemical compound CC([C@H](C1=O)N2C(C(Br)(Br)[C@@H]2Cl)=O)(C)SN1CC1=CC=CC=C1 CLNDZLBRPTYBPL-CMPLNLGQSA-N 0.000 description 2
KGHZYCDDAMUAGN-GRYCIOLGSA-N (4s)-2-benzyl-4-[(2s,3s)-3-bromo-2-chloro-4-oxoazetidin-1-yl]-5,5-dimethyl-1,2-thiazolidin-3-one Chemical compound CC([C@H](C1=O)N2C([C@H](Br)[C@@H]2Cl)=O)(C)SN1CC1=CC=CC=C1 KGHZYCDDAMUAGN-GRYCIOLGSA-N 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
229930182555 Penicillin Natural products 0.000 description 2
KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
150000001408 amides Chemical group 0.000 description 2
239000003782 beta lactam antibiotic agent Substances 0.000 description 2
230000002140 halogenating effect Effects 0.000 description 2
150000000001 isothiazolidines Chemical class 0.000 description 2
239000000463 material Substances 0.000 description 2
239000003960 organic solvent Substances 0.000 description 2
239000007800 oxidant agent Substances 0.000 description 2
230000003647 oxidation Effects 0.000 description 2
238000007254 oxidation reaction Methods 0.000 description 2
229940056360 penicillin g Drugs 0.000 description 2
150000002960 penicillins Chemical class 0.000 description 2
239000011591 potassium Substances 0.000 description 2
229920006395 saturated elastomer Polymers 0.000 description 2
239000007787 solid Substances 0.000 description 2
239000002132 β-lactam antibiotic Substances 0.000 description 2
229940124586 β-lactam antibiotics Drugs 0.000 description 2
ZUWRNQXDZVFRGF-JQWIXIFHSA-N (4s)-2-benzyl-4-[(2r)-3,3-dibromo-2-chloro-4-oxoazetidin-1-yl]-5,5-dimethyl-1,1-dioxo-1,2-thiazolidin-3-one Chemical compound N1([C@@H]2C(S(N(CC=3C=CC=CC=3)C2=O)(=O)=O)(C)C)[C@H](Cl)C(Br)(Br)C1=O ZUWRNQXDZVFRGF-JQWIXIFHSA-N 0.000 description 1
QSVSNIULCKLLIT-NEXRNZHYSA-N (4s)-2-benzyl-4-[(2r)-3,3-dibromo-2-chloro-4-oxoazetidin-1-yl]-5,5-dimethyl-1-oxo-1,2-thiazolidin-3-one Chemical compound N1([C@@H]2C(S(N(CC=3C=CC=CC=3)C2=O)=O)(C)C)[C@H](Cl)C(Br)(Br)C1=O QSVSNIULCKLLIT-NEXRNZHYSA-N 0.000 description 1
ZQSDSRULEVCTPN-VYMLMZJJSA-N (4s)-2-benzyl-4-[(2r,3s)-3-bromo-2-chloro-4-oxoazetidin-1-yl]-5,5-dimethyl-1-oxo-1,2-thiazolidin-3-one Chemical compound N1([C@@H]2C(S(N(CC=3C=CC=CC=3)C2=O)=O)(C)C)[C@H](Cl)[C@@H](Br)C1=O ZQSDSRULEVCTPN-VYMLMZJJSA-N 0.000 description 1
CZSRXHJVZUBEGW-UHFFFAOYSA-N 1,2-thiazolidine Chemical group C1CNSC1 CZSRXHJVZUBEGW-UHFFFAOYSA-N 0.000 description 1
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
JYLNVJYYQQXNEK-UHFFFAOYSA-N 3-amino-2-(4-chlorophenyl)-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(CN)C1=CC=C(Cl)C=C1 JYLNVJYYQQXNEK-UHFFFAOYSA-N 0.000 description 1
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
229930195708 Penicillin V Natural products 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
125000001931 aliphatic group Chemical group 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
125000003460 beta-lactamyl group Chemical group 0.000 description 1
125000002619 bicyclic group Chemical group 0.000 description 1
150000003857 carboxamides Chemical group 0.000 description 1
150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
239000012320 chlorinating reagent Substances 0.000 description 1
239000003814 drug Substances 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
239000005457 ice water Substances 0.000 description 1
239000012442 inert solvent Substances 0.000 description 1
239000010410 layer Substances 0.000 description 1
HHXMXAQDOUCLDN-RXMQYKEDSA-N penem Chemical compound S1C=CN2C(=O)C[C@H]21 HHXMXAQDOUCLDN-RXMQYKEDSA-N 0.000 description 1
RBKMMJSQKNKNEV-RITPCOANSA-N penicillanic acid Chemical compound OC(=O)[C@H]1C(C)(C)S[C@@H]2CC(=O)N21 RBKMMJSQKNKNEV-RITPCOANSA-N 0.000 description 1
229940056367 penicillin v Drugs 0.000 description 1
BPLBGHOLXOTWMN-MBNYWOFBSA-N phenoxymethylpenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)COC1=CC=CC=C1 BPLBGHOLXOTWMN-MBNYWOFBSA-N 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
229910001487 potassium perchlorate Inorganic materials 0.000 description 1
239000000376 reactant Substances 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
BAZAXWOYCMUHIX-UHFFFAOYSA-M sodium perchlorate Chemical compound [Na+].[O-]Cl(=O)(=O)=O BAZAXWOYCMUHIX-UHFFFAOYSA-M 0.000 description 1
229910001488 sodium perchlorate Inorganic materials 0.000 description 1
125000001424 substituent group Chemical group 0.000 description 1
125000005346 substituted cycloalkyl group Chemical group 0.000 description 1
239000000758 substrate Substances 0.000 description 1
150000003457 sulfones Chemical class 0.000 description 1
150000003462 sulfoxides Chemical class 0.000 description 1
230000002195 synergetic effect Effects 0.000 description 1
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
239000008096 xylene Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

SK59-99A 1998-01-20 1999-01-15 1-isothiazolidinone derivatives of azetidine-2-one, process for the preparation thereof and the use thereof SK5999A3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HR980026A HRP980026A2 (en)	1998-01-20	1998-01-20	1-izothiazolydinone derivatives of azetidine-2-ones, processes for the preparation and use thereof

Publications (1)

Publication Number	Publication Date
SK5999A3 true SK5999A3 (en)	2000-04-10

Family

ID=10946682

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK59-99A SK5999A3 (en)	1998-01-20	1999-01-15	1-isothiazolidinone derivatives of azetidine-2-one, process for the preparation thereof and the use thereof

Country Status (11)

Country	Link
EP (1)	EP0930313A1 (cs)
JP (1)	JPH11255767A (cs)
CN (1)	CN1228430A (cs)
BG (1)	BG63013B1 (cs)
CA (1)	CA2256096A1 (cs)
CZ (1)	CZ1999A3 (cs)
HR (1)	HRP980026A2 (cs)
HU (1)	HUP9900123A3 (cs)
NO (1)	NO990226L (cs)
PL (1)	PL330906A1 (cs)
SK (1)	SK5999A3 (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2833842B1 (fr) *	2001-12-21	2004-02-13	Aventis Pharma Sa	Compositions pharmaceutiques a base de derives d'azetidine
WO2016054560A1 (en) *	2014-10-02	2016-04-07	Flatley Discovery Lab	Isoxazole compounds and methods for the treatment of cystic fibrosis
CN108658942B (zh) *	2018-04-28	2020-06-30	中南民族大学	一种基于氧代氮杂环丁烷吡唑羧酸酯化合物及其微波水热法合成方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HRP960131A2 (en) *	1996-03-21	1998-04-30	Pliva Pharm & Chem Works	4-thia-1-azabicyclo(3.2.0)heptane-3-imino-2-isopropylidene-7-oxo analogons of beta-lactams, processes for their preparation and use thereof

1998
- 1998-01-20 HR HR980026A patent/HRP980026A2/hr not_active Application Discontinuation
- 1998-12-25 JP JP10370885A patent/JPH11255767A/ja active Pending
- 1998-12-29 CA CA002256096A patent/CA2256096A1/en not_active Abandoned
1999
- 1999-01-04 CZ CZ9919A patent/CZ1999A3/cs unknown
- 1999-01-05 EP EP99100069A patent/EP0930313A1/en not_active Withdrawn
- 1999-01-15 SK SK59-99A patent/SK5999A3/sk unknown
- 1999-01-15 HU HU9900123A patent/HUP9900123A3/hu unknown
- 1999-01-19 CN CN99100959A patent/CN1228430A/zh active Pending
- 1999-01-19 NO NO990226A patent/NO990226L/no not_active Application Discontinuation
- 1999-01-19 PL PL99330906A patent/PL330906A1/xx unknown
- 1999-01-20 BG BG103103A patent/BG63013B1/bg unknown

Also Published As

Publication number	Publication date
NO990226D0 (no)	1999-01-19
NO990226L (no)	1999-07-21
HU9900123D0 (en)	1999-03-29
HRP980026A2 (en)	1999-10-31
HUP9900123A2 (hu)	1999-09-28
PL330906A1 (en)	1999-08-02
BG103103A (en)	1999-09-30
BG63013B1 (bg)	2001-01-31
HUP9900123A3 (en)	1999-11-29
CN1228430A (zh)	1999-09-15
EP0930313A1 (en)	1999-07-21
CZ1999A3 (cs)	1999-08-11
CA2256096A1 (en)	1999-07-20
JPH11255767A (ja)	1999-09-21

Publication	Publication Date	Title
EP0592677B1 (en)	2001-11-07	Beta-LACTAM COMPOUND AND CEPHEM COMPOUND, AND PRODUCTION THEREOF
PL129534B1 (en)	1984-05-31	Process for preparing novel derivatives of 6-beta-hydroxyalkylpenicillanic acid
CA1090806A (en)	1980-12-02	Oxazolines
HU182664B (en)	1984-02-28	Process for preparing penem-carboxylic acid derivatives and salts thereof
US4060688A (en)	1977-11-29	Cephalosporin intermediates
DE3587237T2 (de)	1993-11-04	1-dethia 2-thia-cephalosporansaeure-derivate, verfahren und zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und sie enthaltende zubereitungen.
JP3121903B2 (ja)	2001-01-09	デアセチルセファロスポラン酸のカルバモイル化方法
US4122086A (en)	1978-10-24	Isopenicillins
JPS6332791B2 (cs)	1988-07-01
US4103086A (en)	1978-07-25	8-Oxo-4-thia-1-azabicyclo (4.2.0)-oct-2-ene derivatives
US4678782A (en)	1987-07-07	3S-formamido azetidinone antibacterial agents, their preparation and use
CZ1999A3 (cs)	1999-08-11	1-isothiazolidinové deriváty azetidin-2-onu, způsoby jejich přípravy a jejich použití
KR960006800B1 (ko)	1996-05-23	카르바페넴을 위한 알케닐실릴아제티디논 중간체
US4393003A (en)	1983-07-12	β-Lactamase inhibitors
COOPER et al.	1982	The chemistry of penicillin sulfoxide
US5466686A (en)	1995-11-14	Amides of 4-oxo-azetidine-2-sulfonic acids and salts thereof, processes for their preparation and their use
JPS6366187A (ja)	1988-03-24	２α−置換ペニシリン誘導体
EP1225176B1 (en)	2003-07-30	Process for preparing exo-methylenepenam compounds
EP0221846A1 (de)	1987-05-13	Optisch aktive Acyloxyazetidinone
HUT66303A (en)	1994-11-28	5-thia-1,4-diazabicyclo[4.2.0]oktane-3.8-dioxo-analogues oh beta-lactame, process for producing them, and use of them
EP0633247B1 (en)	1998-05-27	2-Bromo- and 2-nitroxy derivatives of 3-bromo- and 3,3-dibromo-4-oxo-azetidines, processes for the preparation thereof and use thereof
FR2549835A1 (fr)	1985-02-01	Acides peneme-carboxyliques, leur preparation et leur utilisation therapeutique, notamment en tant qu'agents antibacteriens
HU211955A9 (en)	1996-01-29	5-thia-1,4-diazabicyclo[4.2.0.]octan-3,8-dioxo-béta-lactam analogues, process for preparing them and use thereof
JPH059425B2 (cs)	1993-02-04
BG62565B1 (bg)	2000-02-29	Нови производни на 3-бром- и 3,3-дибром-4-оксо-1-азетидини,метод за тяхното получаване и използването им